Search

Your search keyword '"Lougaris, Vassilios"' showing total 674 results

Search Constraints

Start Over You searched for: Author "Lougaris, Vassilios" Remove constraint Author: "Lougaris, Vassilios"
674 results on '"Lougaris, Vassilios"'

Search Results

1. Long-term safety of hyaluronidase-facilitated subcutaneous immunoglobulin 10%: a European post-authorization study.

2. Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency.

4. Autoantibodies against type I IFNs in humans with alternative NF-κB pathway deficiency

6. Common and Uncommon CT Findings in CVID-Related GL-ILD: Correlations with Clinical Parameters, Therapeutic Decisions and Potential Implications in the Differential Diagnosis

7. Hematopoietic stem cell transplantation for CTLA-4 insufficiency across Europe: A European Society for Blood and Marrow Transplantation Inborn Errors Working Party study

9. Activated phosphoinositide 3-kinase δ syndrome: Update from the ESID Registry and comparison with other autoimmune-lymphoproliferative inborn errors of immunity

10. Scalable GMP-compliant gene correction of CD4+ T cells with IDLV template functionally validated in vitro and in vivo

12. Coronavirus disease 2019 in patients with inborn errors of immunity: An international study

14. Immune tolerance breakdown in inborn errors of immunity: Paving the way to novel therapeutic approaches

15. A randomized, placebo-controlled phase 3 trial of the PI3Kδ inhibitor leniolisib for activated PI3Kδ syndrome

16. The Impact of SARS-CoV-2 Infection in Patients with Inborn Errors of Immunity: the Experience of the Italian Primary Immunodeficiencies Network (IPINet)

18. Progressive Depletion of B and T Lymphocytes in Patients with Ataxia Telangiectasia: Results of the Italian Primary Immunodeficiency Network

20. Immunological Evaluation of Patients Affected with Jacobsen Syndrome Reveals Profound Not Age-Related Lymphocyte Alterations

22. Initial presenting manifestations in 16,486 patients with inborn errors of immunity include infections and noninfectious manifestations

24. Corrigendum: Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content

25. Natural Killer Cells from Patients with Recombinase-Activating Gene and Non-Homologous End Joining Gene Defects Comprise a Higher Frequency of CD56bright NKG2A+++ Cells, and Yet Display Increased Degranulation and Higher Perforin Content

27. Long-term safety of hyaluronidase-facilitated subcutaneous immunoglobulin 10%: a European post-authorization study

28. λ5 Deficiency

29. X-linked Agammaglobulinemia (BTK Deficiency)

30. μ Heavy Chain Deficiency

32. PIK3R1 Deficiency-Associated Agammaglobulinemia

33. Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality

34. Vasculitis and vasculopathy associated with inborn errors of immunity: an overview

35. The Italian Registry for Primary Immunodeficiencies (Italian Primary Immunodeficiency Network; IPINet): Twenty Years of Experience (1999–2019)

36. Prevalence of Immunological Defects in a Cohort of 97 Rubinstein–Taybi Syndrome Patients

39. Double-blind, placebo-controlled, randomized trial on low-dose azithromycin prophylaxis in patients with primary antibody deficiencies

40. Long-Term Outcome of WHIM Syndrome in 18 Patients: High Risk of Lung Disease and HPV-Related Malignancies

41. Comparison of Common Monogenic Defects in a Large Predominantly Antibody Deficiency Cohort

42. Unbiased assessment of genome integrity and purging of adverse outcomes at the target locus upon editing of CD4+ T‐cells for the treatment of Hyper IgM1

45. Interim analysis: Open-label extension study of leniolisib for patients with APDS

48. Contributors

Catalog

Books, media, physical & digital resources